Health: Lynch backing aids Neurence’s prospects, Merck KGaA:...

To view this email as a webpage, click here     Friday December 06 2013     Health   Lynch backing aids Neurence's prospects   Neurence, which describes itself as 'a brain in the cloud' is two steps ahead of pack competing to turn augmented reality into commercial reality       Merck KGaA: chemical weapon     Teva chief in favour of board diversity     Nutrition fails to fuel Science in Sport               Manage email    Forward this email   Feedback    Manage portfolio Subscribe to the FT Follow the FT   Unsubscribe | My Account | RSS | Privacy Policy | About Us | Help   © THE FINANCIAL TIMES LTD 2013 You have received this email because you have signed up from the NBE preference page. This email was sent by a company owned by Pearson plc, registered office at 80 Strand, London WC2R 0RL. Registered in England and Wales with company number 53723.